463 related articles for article (PubMed ID: 33940597)
41. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia.
Clavijo LC; Al-Asady N; Dhillon A; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):516-520. PubMed ID: 29221961
[TBL] [Abstract][Full Text] [Related]
42. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
[TBL] [Abstract][Full Text] [Related]
43. Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin.
Schwarz S; Gockel LM; Naggi A; Barash U; Gobec M; Bendas G; Schlesinger M
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110917
[TBL] [Abstract][Full Text] [Related]
44. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
[TBL] [Abstract][Full Text] [Related]
45. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.
Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD
Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147
[TBL] [Abstract][Full Text] [Related]
46. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
47. Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
Passacquale G; Ferro A
Br J Clin Pharmacol; 2011 Oct; 72(4):604-18. PubMed ID: 21223359
[TBL] [Abstract][Full Text] [Related]
48. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
49. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
Khodadi E
Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
[TBL] [Abstract][Full Text] [Related]
50. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device.
Sheriff J; Girdhar G; Chiu WC; Jesty J; Slepian MJ; Bluestein D
J Thromb Thrombolysis; 2014 May; 37(4):499-506. PubMed ID: 24043375
[TBL] [Abstract][Full Text] [Related]
51. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
Lettino M; Leonardi S; De Maria E; Halvorsen S
Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
[TBL] [Abstract][Full Text] [Related]
52. Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction.
Ghosh K; Khare A; Shetty S; Nair S; Kulkarni B; Mohanty D
Natl Med J India; 2006; 19(2):73-4. PubMed ID: 16756193
[TBL] [Abstract][Full Text] [Related]
53. Arsenic May Act as a Pro-Metastatic Carcinogen Through Promoting Tumor Cell-Induced Platelet Aggregation.
Kim K; Heo YK; Chun S; Kim CH; Bian Y; Bae ON; Lee MY; Lim KM; Chung JH
Toxicol Sci; 2019 Mar; 168(1):18-27. PubMed ID: 30428081
[TBL] [Abstract][Full Text] [Related]
54. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of platelet function: does it offer a chance of better cancer progression control?
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
[TBL] [Abstract][Full Text] [Related]
56. Anti-platelet treatments in cancer: Basic and clinical research.
Gresele P; Malvestiti M; Momi S
Thromb Res; 2018 Apr; 164 Suppl 1():S106-S111. PubMed ID: 29703466
[TBL] [Abstract][Full Text] [Related]
57. Platelet biology and functions: new concepts and clinical perspectives.
van der Meijden PEJ; Heemskerk JWM
Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
[TBL] [Abstract][Full Text] [Related]
58. Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.
Johnson KE; Forward JA; Tippy MD; Ceglowski JR; El-Husayni S; Kulenthirarajan R; Machlus KR; Mayer EL; Italiano JE; Battinelli EM
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):664-674. PubMed ID: 28153880
[TBL] [Abstract][Full Text] [Related]
59. Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
van Geffen JP; Kleinegris MC; Verdoold R; Baaten CC; Cosemans JM; Clemetson KJ; Ten Cate H; Roest M; de Laat B; Heemskerk JW
Thromb Res; 2015 Mar; 135(3):513-20. PubMed ID: 25600441
[TBL] [Abstract][Full Text] [Related]
60. Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis.
Johnson KE; Ceglowski JR; Roweth HG; Forward JA; Tippy MD; El-Husayni S; Kulenthirarajan R; Malloy MW; Machlus KR; Chen WY; Italiano JE; Battinelli EM
Blood Adv; 2019 Jan; 3(2):198-211. PubMed ID: 30670536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
